Direct endovascular thrombectomy for patients with acute ischemic stroke failed to achieve non-inferiority to combined bridging thrombolysis plus endovascular therapy, in a new meta-analysis.
The ENCHANTED2/MT trial, which was investigating intensive lowering of blood pressure in acute ischemic stroke patients after mechanical thrombectomy, has been stopped early due to safety concerns.
The MR CLEAN-LATE trial shows patients selected for thrombectomy on the presence of collateral flow had a greater chance of a better functional outcome than those not receiving endovascular therapy.